Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Nyxoah SA - Ordinary Shares (NQ:NYXH)

3.011 -0.059 (-1.92%)
Streaming Delayed Price Updated: 9:51 AM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,516
Open 3.020
Bid (Size) 3.000 (1,000)
Ask (Size) 3.080 (500)
Prev. Close 3.070
Today's Range 3.010 - 3.040
52wk Range 2.760 - 8.640
Shares Outstanding 28,673,985
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nyxoah Q1 Earnings Call Highlights ↗
Nyxoah (NASDAQ:NYXH) reported 13% sequential worldwide net revenue growth in the first quarter of 2026, driven primarily by continued adoption of its Genio system in the United States, where the... 
Via MarketBeat
Topics Earnings
News headline image
Nyxoah Reports First Quarter 2026 Financial and Operating Results
From Nyxoah
Via GlobeNewswire

Performance

YTD
-33.1%
-33.1%
1 Month
+1.7%
+1.7%
3 Month
-35.1%
-35.1%
6 Month
-46.7%
-46.7%
1 Year
-49.6%
-49.6%

More News

Read More
News headline image
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah (NYXH) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notification
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notification
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah SA (NASDAQ: NYXH): A Deep Dive into its Bilateral Approach to Sleep Apnea
Via PredictStreet
Topics Initial Public Offering Intellectual Property
News headline image
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy ↗
Via Stocktwits
News headline image
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
From Nyxoah
Via GlobeNewswire

Frequently Asked Questions

Is Nyxoah SA - Ordinary Shares publicly traded?
Yes, Nyxoah SA - Ordinary Shares is publicly traded.
What exchange does Nyxoah SA - Ordinary Shares trade on?
Nyxoah SA - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Nyxoah SA - Ordinary Shares?
The ticker symbol for Nyxoah SA - Ordinary Shares is NYXH on the Nasdaq Stock Market
What is the current price of Nyxoah SA - Ordinary Shares?
The current price of Nyxoah SA - Ordinary Shares is 3.011
When was Nyxoah SA - Ordinary Shares last traded?
The last trade of Nyxoah SA - Ordinary Shares was at 05/13/26 09:51 AM ET
What is the market capitalization of Nyxoah SA - Ordinary Shares?
The market capitalization of Nyxoah SA - Ordinary Shares is 86.34M
How many shares of Nyxoah SA - Ordinary Shares are outstanding?
Nyxoah SA - Ordinary Shares has 86M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.